血栓摘出術用デバイス市場。世界の産業動向、シェア、サイズ、成長、機会、そして2021-2026年の予測Thrombectomy Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026 The global thrombectomy devices market reached a value of US$ 1.14 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 6.05% during 2021-2026. Keeping in mind the ... もっと見る
サマリーThe global thrombectomy devices market reached a value of US$ 1.14 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 6.05% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use sectors. These insights are included in the report as a major market contributor.Thrombectomy devices offer numerous benefits in surrogate endpoints, such as biomarker analysis, infarct size reduction, ST-segment resolution and angiographic thrombolysis in myocardial infarction (TIMI) flow. These devices minimize blood loss and damage caused to the vessel wall during a procedure. Consequently, they find application in treating blood clots present in veins, arteries and capillaries. They are also used to treat pulmonary embolism and peripheral arterial diseases. At present, they are widely available in different sizes and diameters, depending on the affected area. Some of the most frequently used thrombectomy devices procedures are balloon embolectomy, surgical embolectomy and aspiration embolectomy. Global Thrombectomy Devices Market Trends: According to the World Health Organization (WHO), chronic diseases are the leading causes of death and disability around the world. Disease rates from these conditions are accelerating significantly on account of hectic schedules, sedentary lifestyles, rising consumption of fast food and the increasing number of individuals who smoke and consume alcohol. This represents one of the key factors propelling the growth of the thrombectomy devices market worldwide. Moreover, the growing geriatric population, along with the escalating demand for minimally invasive (MI) procedures and improving healthcare infrastructure in various countries, is also fueling the growth of the market. Furthermore, the leading manufacturers are increasing their investments in research and development (R&D) activities to introduce technologically advanced thrombectomy devices, which, in turn, is creating a positive outlook for the market. Besides this, favorable medical reimbursements and rising preference of these devices by surgeons for performing image-guided surgeries are anticipated to strengthen the market growth. Key Market Segmentation: IMARC Group provides an analysis of the key trends in each sub-segment of the global thrombectomy devices market, along with forecasts at the global, regional and country-level from 2021-2026. Our report has categorized the market based on region, product type, application, and end-user. Breakup by Product Type: Aspiration Thrombectomy Devices Mechanical Thrombectomy Devices Ultrasonic Thrombectomy Devices Others Breakup by Application: Cardiovascular Neurovascular Peripheral Vascular Breakup by End User: Hospitals and Clinics Ambulatory Surgical Centers Others Breakup by Region: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being Argon Medical Devices Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Johnson & Johnson, Medtronic Plc, Penumbra Inc., Spectranetics Corporation (Koninklijke Philips N.V.), Stryker Corporation, Teleflex Incorporated and Terumo Corporation. Key Questions Answered in This Report: How has the global thrombectomy devices market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global thrombectomy devices market? What are the key regional markets? What is the breakup of the market based on the product type? What is the breakup of the market based on the application? What is the breakup of the market based on the end-user? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global thrombectomy devices market and who are the key players? What is the degree of competition in the industry? 目次1 Preface2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Thrombectomy Devices Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Product Type 6.1 Aspiration Thrombectomy Devices 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Mechanical Thrombectomy Devices 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Ultrasonic Thrombectomy Devices 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 Others 6.4.1 Market Trends 6.4.2 Market Forecast 7 Market Breakup by Application 7.1 Cardiovascular 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Neurovascular 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Peripheral Vascular 7.3.1 Market Trends 7.3.2 Market Forecast 8 Market Breakup by End User 8.1 Hospitals and Clinics 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Ambulatory Surgical Centers 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Others 8.3.1 Market Trends 8.3.2 Market Forecast 9 Market Breakup by Region 9.1 North America 9.1.1 United States 9.1.1.1 Market Trends 9.1.1.2 Market Forecast 9.1.2 Canada 9.1.2.1 Market Trends 9.1.2.2 Market Forecast 9.2 Asia-Pacific 9.2.1 China 9.2.1.1 Market Trends 9.2.1.2 Market Forecast 9.2.2 Japan 9.2.2.1 Market Trends 9.2.2.2 Market Forecast 9.2.3 India 9.2.3.1 Market Trends 9.2.3.2 Market Forecast 9.2.4 South Korea 9.2.4.1 Market Trends 9.2.4.2 Market Forecast 9.2.5 Australia 9.2.5.1 Market Trends 9.2.5.2 Market Forecast 9.2.6 Indonesia 9.2.6.1 Market Trends 9.2.6.2 Market Forecast 9.2.7 Others 9.2.7.1 Market Trends 9.2.7.2 Market Forecast 9.3 Europe 9.3.1 Germany 9.3.1.1 Market Trends 9.3.1.2 Market Forecast 9.3.2 France 9.3.2.1 Market Trends 9.3.2.2 Market Forecast 9.3.3 United Kingdom 9.3.3.1 Market Trends 9.3.3.2 Market Forecast 9.3.4 Italy 9.3.4.1 Market Trends 9.3.4.2 Market Forecast 9.3.5 Spain 9.3.5.1 Market Trends 9.3.5.2 Market Forecast 9.3.6 Russia 9.3.6.1 Market Trends 9.3.6.2 Market Forecast 9.3.7 Others 9.3.7.1 Market Trends 9.3.7.2 Market Forecast 9.4 Latin America 9.4.1 Brazil 9.4.1.1 Market Trends 9.4.1.2 Market Forecast 9.4.2 Mexico 9.4.2.1 Market Trends 9.4.2.2 Market Forecast 9.4.3 Others 9.4.3.1 Market Trends 9.4.3.2 Market Forecast 9.5 Middle East and Africa 9.5.1 Market Trends 9.5.2 Market Breakup by Country 9.5.3 Market Forecast 10 SWOT Analysis 10.1 Overview 10.2 Strengths 10.3 Weaknesses 10.4 Opportunities 10.5 Threats 11 Value Chain Analysis 12 Porters Five Forces Analysis 12.1 Overview 12.2 Bargaining Power of Buyers 12.3 Bargaining Power of Suppliers 12.4 Degree of Competition 12.5 Threat of New Entrants 12.6 Threat of Substitutes 13 Price Analysis 14 Competitive Landscape 14.1 Market Structure 14.2 Key Players 14.3 Profiles of Key Players 14.3.1 Argon Medical Devices Inc. 14.3.1.1 Company Overview 14.3.1.2 Product Portfolio 14.3.2 Boston Scientific Corporation 14.3.2.1 Company Overview 14.3.2.2 Product Portfolio 14.3.2.3 Financials 14.3.2.4 SWOT Analysis 14.3.3 Edwards Lifesciences Corporation 14.3.3.1 Company Overview 14.3.3.2 Product Portfolio 14.3.3.3 Financials 14.3.3.4 SWOT Analysis 14.3.4 Johnson & Johnson 14.3.4.1 Company Overview 14.3.4.2 Product Portfolio 14.3.4.3 Financials 14.3.4.4 SWOT Analysis 14.3.5 Medtronic Plc 14.3.5.1 Company Overview 14.3.5.2 Product Portfolio 14.3.5.3 Financials 14.3.5.4 SWOT Analysis 14.3.6 Penumbra Inc. 14.3.6.1 Company Overview 14.3.6.2 Product Portfolio 14.3.6.3 Financials 14.3.7 Spectranetics Corporation (Koninklijke Philips N.V.) 14.3.7.1 Company Overview 14.3.7.2 Product Portfolio 14.3.8 Stryker Corporation 14.3.8.1 Company Overview 14.3.8.2 Product Portfolio 14.3.8.3 Financials 14.3.8.4 SWOT Analysis 14.3.9 Teleflex Incorporated 14.3.9.1 Company Overview 14.3.9.2 Product Portfolio 14.3.9.3 Financials 14.3.9.4 SWOT Analysis 14.3.10 Terumo Corporation 14.3.10.1 Company Overview 14.3.10.2 Product Portfolio 14.3.10.3 Financials 14.3.10.4 SWOT Analysis
SummaryThe global thrombectomy devices market reached a value of US$ 1.14 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 6.05% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use sectors. These insights are included in the report as a major market contributor.Thrombectomy devices offer numerous benefits in surrogate endpoints, such as biomarker analysis, infarct size reduction, ST-segment resolution and angiographic thrombolysis in myocardial infarction (TIMI) flow. These devices minimize blood loss and damage caused to the vessel wall during a procedure. Consequently, they find application in treating blood clots present in veins, arteries and capillaries. They are also used to treat pulmonary embolism and peripheral arterial diseases. At present, they are widely available in different sizes and diameters, depending on the affected area. Some of the most frequently used thrombectomy devices procedures are balloon embolectomy, surgical embolectomy and aspiration embolectomy. Global Thrombectomy Devices Market Trends: According to the World Health Organization (WHO), chronic diseases are the leading causes of death and disability around the world. Disease rates from these conditions are accelerating significantly on account of hectic schedules, sedentary lifestyles, rising consumption of fast food and the increasing number of individuals who smoke and consume alcohol. This represents one of the key factors propelling the growth of the thrombectomy devices market worldwide. Moreover, the growing geriatric population, along with the escalating demand for minimally invasive (MI) procedures and improving healthcare infrastructure in various countries, is also fueling the growth of the market. Furthermore, the leading manufacturers are increasing their investments in research and development (R&D) activities to introduce technologically advanced thrombectomy devices, which, in turn, is creating a positive outlook for the market. Besides this, favorable medical reimbursements and rising preference of these devices by surgeons for performing image-guided surgeries are anticipated to strengthen the market growth. Key Market Segmentation: IMARC Group provides an analysis of the key trends in each sub-segment of the global thrombectomy devices market, along with forecasts at the global, regional and country-level from 2021-2026. Our report has categorized the market based on region, product type, application, and end-user. Breakup by Product Type: Aspiration Thrombectomy Devices Mechanical Thrombectomy Devices Ultrasonic Thrombectomy Devices Others Breakup by Application: Cardiovascular Neurovascular Peripheral Vascular Breakup by End User: Hospitals and Clinics Ambulatory Surgical Centers Others Breakup by Region: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being Argon Medical Devices Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Johnson & Johnson, Medtronic Plc, Penumbra Inc., Spectranetics Corporation (Koninklijke Philips N.V.), Stryker Corporation, Teleflex Incorporated and Terumo Corporation. Key Questions Answered in This Report: How has the global thrombectomy devices market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global thrombectomy devices market? What are the key regional markets? What is the breakup of the market based on the product type? What is the breakup of the market based on the application? What is the breakup of the market based on the end-user? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global thrombectomy devices market and who are the key players? What is the degree of competition in the industry? Table of Contents1 Preface2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Thrombectomy Devices Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Product Type 6.1 Aspiration Thrombectomy Devices 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Mechanical Thrombectomy Devices 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Ultrasonic Thrombectomy Devices 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 Others 6.4.1 Market Trends 6.4.2 Market Forecast 7 Market Breakup by Application 7.1 Cardiovascular 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Neurovascular 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Peripheral Vascular 7.3.1 Market Trends 7.3.2 Market Forecast 8 Market Breakup by End User 8.1 Hospitals and Clinics 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Ambulatory Surgical Centers 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Others 8.3.1 Market Trends 8.3.2 Market Forecast 9 Market Breakup by Region 9.1 North America 9.1.1 United States 9.1.1.1 Market Trends 9.1.1.2 Market Forecast 9.1.2 Canada 9.1.2.1 Market Trends 9.1.2.2 Market Forecast 9.2 Asia-Pacific 9.2.1 China 9.2.1.1 Market Trends 9.2.1.2 Market Forecast 9.2.2 Japan 9.2.2.1 Market Trends 9.2.2.2 Market Forecast 9.2.3 India 9.2.3.1 Market Trends 9.2.3.2 Market Forecast 9.2.4 South Korea 9.2.4.1 Market Trends 9.2.4.2 Market Forecast 9.2.5 Australia 9.2.5.1 Market Trends 9.2.5.2 Market Forecast 9.2.6 Indonesia 9.2.6.1 Market Trends 9.2.6.2 Market Forecast 9.2.7 Others 9.2.7.1 Market Trends 9.2.7.2 Market Forecast 9.3 Europe 9.3.1 Germany 9.3.1.1 Market Trends 9.3.1.2 Market Forecast 9.3.2 France 9.3.2.1 Market Trends 9.3.2.2 Market Forecast 9.3.3 United Kingdom 9.3.3.1 Market Trends 9.3.3.2 Market Forecast 9.3.4 Italy 9.3.4.1 Market Trends 9.3.4.2 Market Forecast 9.3.5 Spain 9.3.5.1 Market Trends 9.3.5.2 Market Forecast 9.3.6 Russia 9.3.6.1 Market Trends 9.3.6.2 Market Forecast 9.3.7 Others 9.3.7.1 Market Trends 9.3.7.2 Market Forecast 9.4 Latin America 9.4.1 Brazil 9.4.1.1 Market Trends 9.4.1.2 Market Forecast 9.4.2 Mexico 9.4.2.1 Market Trends 9.4.2.2 Market Forecast 9.4.3 Others 9.4.3.1 Market Trends 9.4.3.2 Market Forecast 9.5 Middle East and Africa 9.5.1 Market Trends 9.5.2 Market Breakup by Country 9.5.3 Market Forecast 10 SWOT Analysis 10.1 Overview 10.2 Strengths 10.3 Weaknesses 10.4 Opportunities 10.5 Threats 11 Value Chain Analysis 12 Porters Five Forces Analysis 12.1 Overview 12.2 Bargaining Power of Buyers 12.3 Bargaining Power of Suppliers 12.4 Degree of Competition 12.5 Threat of New Entrants 12.6 Threat of Substitutes 13 Price Analysis 14 Competitive Landscape 14.1 Market Structure 14.2 Key Players 14.3 Profiles of Key Players 14.3.1 Argon Medical Devices Inc. 14.3.1.1 Company Overview 14.3.1.2 Product Portfolio 14.3.2 Boston Scientific Corporation 14.3.2.1 Company Overview 14.3.2.2 Product Portfolio 14.3.2.3 Financials 14.3.2.4 SWOT Analysis 14.3.3 Edwards Lifesciences Corporation 14.3.3.1 Company Overview 14.3.3.2 Product Portfolio 14.3.3.3 Financials 14.3.3.4 SWOT Analysis 14.3.4 Johnson & Johnson 14.3.4.1 Company Overview 14.3.4.2 Product Portfolio 14.3.4.3 Financials 14.3.4.4 SWOT Analysis 14.3.5 Medtronic Plc 14.3.5.1 Company Overview 14.3.5.2 Product Portfolio 14.3.5.3 Financials 14.3.5.4 SWOT Analysis 14.3.6 Penumbra Inc. 14.3.6.1 Company Overview 14.3.6.2 Product Portfolio 14.3.6.3 Financials 14.3.7 Spectranetics Corporation (Koninklijke Philips N.V.) 14.3.7.1 Company Overview 14.3.7.2 Product Portfolio 14.3.8 Stryker Corporation 14.3.8.1 Company Overview 14.3.8.2 Product Portfolio 14.3.8.3 Financials 14.3.8.4 SWOT Analysis 14.3.9 Teleflex Incorporated 14.3.9.1 Company Overview 14.3.9.2 Product Portfolio 14.3.9.3 Financials 14.3.9.4 SWOT Analysis 14.3.10 Terumo Corporation 14.3.10.1 Company Overview 14.3.10.2 Product Portfolio 14.3.10.3 Financials 14.3.10.4 SWOT Analysis
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(電子部品/半導体)の最新刊レポート
IMARC Services Private Limited.社のその他分野での最新刊レポート
本レポートと同じKEY WORD(devices)の最新刊レポート
よくあるご質問IMARC Services Private Limited.社はどのような調査会社ですか?インドに調査拠点を持つ調査会社。幅広い分野をカバーしていますがケミカルに特に焦点を当てています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/26 10:26 155.24 円 162.59 円 197.14 円 |